drugset / Trial / NCT00502463
Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial
Completed
51 enrolled
Austrian South Oncology Group
Change of sponsor 2008: new sponsor AGMT · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the trial is to determine the feasibility of an induction chemotherapy with radio-immunotherapy in patients with head and neck cancer stage III/IV
Timeline
- Start
- 2007-10-03
- Primary completion
- 2010-01-19
- Completion
- 2014-01-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetuximab | Monoclonal antibody | 250 mg/m2 | — |
| Subject | Cisplatin | Other / unclassified | 75 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 75 mg/m2 | — |
| Subject | fluorouracil | Small molecule | 750 mg/m2 | — |